IIIvan Ivanov

Ivan Ivanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ivan Ivanov has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular Mechanism of the Anti-Inflammatory Action of Heparin

    by Leandar Litov, Peicho Petkov, Miroslav Rangelov, Nevena Ilieva, Elena Lilkova, Nadezhda Todorova, Elena Krachmarova, Kristina Malinova, Anastas Gospodinov, Rossitsa Hristova, et al.

    Our objective is to reveal the molecular mechanism of the anti-inflammatory action of low-molecular-weight heparin (LMWH) based on its influence on the activity of two key cytokines, IFNγ and IL-6. The mechanism of heparin binding to IFNγ and IL-6 and the resulting inhibition of their activity were studied by means of extensive molecular-dynamics simulations. The effect of LMWH on IFNγ signalling inside stimulated WISH cells was investigated by measuring its antiproliferative activity and the translocation of phosphorylated STAT1 in the nucleus. We found that LMWH binds with high affinity to IFNγ and is able to fully inhibit the interaction with its cellular receptor. It also influences the biological activity of IL-6 by binding to either IL-6 or IL-6/IL-6Rα, thus preventing the formation of the IL-6/IL-6Rα/gp130 signalling complex. These findings shed light on the molecular mechanism of the anti-inflammatory action of LMWH and underpin its ability to influence favourably conditions characterised by overexpression of these two cytokines. Such conditions are not only associated with autoimmune diseases, but also with inflammatory processes, in particular with COVID-19. Our results put forward heparin as a promising means for the prevention and suppression of severe CRS and encourage further investigations on its applicability as an anti-inflammatory agent.


  • Open Access

    Heparin as an Anti-Inflammatory Agent

    by Leandar Litov, Peicho Petkov, Miroslav Rangelov, Nevena Ilieva, Elena Lilkova, Nadezhda Todorova, Elena Krachmarova, Kristina Malinova, Anastas Gospodinov, Rossitsa Hristova, et al.

    Timely control of the cytokine release syndrome (CRS) at the severe stage of COVID-19 is key to improving the treatment success and reducing the mortality rate. The inhibition of the activity of the two key cytokines, IFNγ and IL-6, can significantly reduce or even reverse the development of the cytokine storm. The objective of our investigations is to reveal the anti-inflammatory potential of heparin for prevention and suppression of the development of CRS in acute COVID-19 patients. The effect of low-molecular-weight heparin (LMWH) on IFNγ signalling inside the stimulated WISH cells was investigated by measuring its antiproliferative activity and the translocation of phosphorylated STAT1 in the nucleus. The mechanism of heparin binding to IFNγ and IL-6 and therefore inhibition of their activity was studied by means of extensive molecular-dynamics simulations. We find that LMWH binds with high affinity to IFNγ and is able to inhibit fully the interaction with its cellular receptor. It also influences the biological activity of IL-6 by binding to either IL-6 or IL-6/IL-6Rα thus preventing the formation of the IL-6/IL-6Rα/gp130 signaling complex. Our conclusion is that heparin is a potent anti-inflammatory agent that can be used in acute inflammatory conditions, due to its potential to inhibit both IFN γ and IL-6 signalling pathways. Based on our results and available clinical observations, we suggest the administration of LMWH to COVID-19 patients in the initial stages of the acute phase. The beginning of the treatment and the dosage should be based on a careful follow-up of the platelet count and the D-dimer, IL-6, IFN, T-cells, and B-cells levels.


  • Open Access

    Effects of a recombinant gene expression on ColE1-like plasmid segregation in Escherichia coli

    by Mladen Popov, Stefan Petrov, Genoveva Nacheva, Ivan Ivanov, Udo Reichl

    Segregation of expression plasmids leads to loss of recombinant DNA from transformed bacterial cells due to the irregular distribution of plasmids between the daughter cells during cell division. Under non-selective conditions this segregational instability results in a heterogeneous population of cells, where the non-productive plasmid-free cells overgrow the plasmid-bearing cells thus decreasing the yield of recombinant protein. Amongst the factors affecting segregational plasmid instability are: the plasmid design, plasmid copy-number, host cell genotype, fermentation conditions etc. This study aims to investigate the influence of transcription and translation on the segregation of recombinant plasmids designed for constitutive gene expression in Escherichia coli LE392 at glucose-limited continuous cultivation. To this end a series of pBR322-based plasmids carrying a synthetic human interferon-gamma (hIFNγ) gene placed under the control of different regulatory elements (promoter and ribosome-binding sites) were used as a model. Bacterial growth and product formation kinetics of transformed E. coli LE392 cells cultivated continuously were described by a structured kinetic model proposed by Lee et al. (1985). The obtained results demonstrated that both transcription and translation efficiency strongly affected plasmid segregation. The segregation of plasmid having a deleted promoter did not exceed 5% after 190 h of cultivation. The observed high plasmid stability was not related with an increase in the plasmid copy-number. A reverse correlation between the yield of recombinant protein (as modulated by using different ribosome binding sites) and segregational plasmid stability (determined by the above model) was also observed. Switching-off transcription of the hIFNγ gene has a stabilising effect on ColE1-like plasmids against segregation, which is not associated with an increase in the plasmid copy-number. The increased constitutive gene expression has a negative effect on segregational plasmid stability. A kinetic model proposed by Lee et al. (1985) was appropriate for description of E. coli cell growth and recombinant product formation in chemostat cultivations.


  • Open Access

    Evidence for Excretion of Glycation Agents fromE. ColiCells During Growth

    by L.N. Srebreva, G.A. Stoynev, I.G. Ivanov

    Recently we have hypothesised that bacteria might have some protective mechanism for elimination of highly reactive carbonyl (glycating) compounds out of the cell (3). To check this hypothesis, we have studied here the ability of bacterial culture media obtained after overnight cultivation of E. coli AB 1157 cells to glycate a lysine rich protein (histone H1). Four different methods were applied for identification of glycation products in the reporter protein: fluorescence spectroscopy, ELISA, Polyacrylamide gel electrophoresis (PAGE) and determination of reactive carbonyl groups. The obtained results showed an increased fluorescence at λem = 440 nm upon excitation at 370 nm (specific for the advanced glycation end products, AGEs), elevated content of reactive carbonyls in the reporter protein and immunoreactivity with an imidazolone specific monoclonal antibody. PAGE also revealed changes in the treated histone H1 (fragmentation and covalent aggregation) which were typical for glycated proteins. All these together make it reasonable to conclude that the bacterial culture media contain reactive glycating compounds excreted from the E. coli cells during their growth.